Clinical Trial Results:
A Multicenter, Randomized, Double-Blind, Phase 3b Trial to Evaluate the Efficacy and
Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin in Combination with
Metformin in Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control on Insulin Alone or on Insulin in Combination with Metformin
+ Pharmacogenetics Blood Sample Protocol Amendment 1 (v1.0, Date 13-Aug-2008)
Summary
|
|
EudraCT number |
2008-001089-10 |
Trial protocol |
FR HU PL GB |
Global completion date |
01 Sep 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Dec 2016
|
First version publication date |
03 Dec 2016
|
Other versions |
|
Summary report(s) |
CV102-057 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.